[ Price : $8.95]
FDA approves a Biogen NDA for Vumerity (diroximel fumarate) for treating relapsing forms of multiple sclerosis.[ Price : $8.95]
FDA grants Breakthrough Device status to Med-botics for its Oxalert EPO (Enhanced Pulse Oximeter), a wrist-worn arousal device des...[ Price : $8.95]
FDA approves an Impulse Dynamics PMA supplement for its next generation of the implantable Optimizer Smart System for delivering c...[ Price : $8.95]
CDRHer Charles Viviano explains on a Webinar a new guidance on how the Center is flexible in weighing uncertainty in making medica...[ Price : $8.95]
FDA says an Ethicon recall of its Echelon Flex staplers is Class 1.[ Price : $8.95]
CDER director Janet Woodcock says advanced manufacturing technologies could reduce U.S. drug maker reliance on foreign-sourced act...[ Price : $8.95]
Federal Register notice: FDA proposes to withdraw approval of a Watson Laboratories ANDA for oxycodone hydrochloride and ibuprofen...[ Price : $8.95]
Federal Register notice: FDA proposes to withdraw approval of an InvaGen Pharmaceuticals ANDA for trandolapril tablets.